|
gptkbp:instanceOf
|
gptkb:nonprofit_organization
|
|
gptkbp:abbreviation
|
gptkb:DNDi
|
|
gptkbp:awards
|
gptkb:BBVA_Foundation_Frontiers_of_Knowledge_Award_(2018)
gptkb:Prince_Mahidol_Award_(2011)
|
|
gptkbp:collaboratesWith
|
academic institutions
governments
public health agencies
non-governmental organizations
pharmaceutical companies
|
|
gptkbp:director
|
gptkb:Dr._Luis_Pizarro
|
|
gptkbp:focus
|
drug development
neglected diseases
|
|
gptkbp:founded
|
2003
|
|
gptkbp:founder
|
gptkb:World_Health_Organization
gptkb:Institut_Pasteur
gptkb:Kenya_Medical_Research_Institute
gptkb:Médecins_Sans_Frontières
gptkb:Oswaldo_Cruz_Foundation
gptkb:Indian_Council_of_Medical_Research
gptkb:Ministry_of_Health_Malaysia
|
|
gptkbp:fullName
|
gptkb:Drugs_for_Neglected_Diseases_initiative
|
|
gptkbp:headquartersLocation
|
gptkb:Geneva,_Switzerland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DNDi
|
|
gptkbp:industry
|
pharmaceutical research
|
|
gptkbp:legalStatus
|
gptkb:foundation
|
|
gptkbp:mission
|
to develop new treatments for neglected diseases
|
|
gptkbp:notableProject
|
Chagas disease drug development
fexinidazole for sleeping sickness
hepatitis C affordable treatments
leishmaniasis drug development
paediatric HIV treatments
|
|
gptkbp:numberOfEmployees
|
over 200
|
|
gptkbp:operatesIn
|
gptkb:Africa
gptkb:Asia
gptkb:Europe
gptkb:Latin_America
gptkb:North_America
|
|
gptkbp:regionServed
|
global
|
|
gptkbp:status
|
active
|
|
gptkbp:type
|
public-private partnership
|
|
gptkbp:website
|
https://www.dndi.org/
|
|
gptkbp:開発製品
|
gptkb:fexinidazole
gptkb:ravidasvir/sofosbuvir
benznidazole for Chagas disease
combination therapies for malaria
paediatric formulations of HIV drugs
treatments for visceral leishmaniasis
|
|
gptkbp:bfsParent
|
gptkb:Drug_Discovery_Unit
|
|
gptkbp:bfsLayer
|
6
|